Perioperative Risk Assessment for Surgery of Consecutive Cases with Ventricular Septal Rupture: Seeking A Novel and Comprehensive Method

Authors

  • Lu Wang, BA Department of Anesthesiology, Peking University People’s Hospital, Beijing, China
  • Ting Hai, MD Department of Anesthesiology, Peking University People’s Hospital, Beijing, China
  • Yi Feng, MD Department of Anesthesiology, Peking University People’s Hospital, Beijing, China
  • Qiaoyu Han, MD Department of Anesthesiology, Peking University People’s Hospital, Beijing, China
  • Yaru Li, BA Department of Anesthesiology, Peking University People’s Hospital, Beijing, China
  • Yu Chen, MD Department of Cardiac Surgery, Peking University People’s Hospital, Beijing, China
  • Wei Yang, MD Department of Cardiac Surgery, Peking University People’s Hospital, Beijing, China
  • Zhou Zhao, MD Department of Cardiac Surgery, Peking University People’s Hospital, Beijing, China
  • Luyang Jiang, MD Department of Anesthesiology, Peking University People’s Hospital, Beijing, China

DOI:

https://doi.org/10.1532/hsf.3753

Keywords:

risk assessment, ventricular septal rupture, surgical procedures

Abstract

Background: Ventricular septal rupture (VSR) is a rare but lethal complication occurring after acute myocardial infarction. The aim of our study was to review the single-center experience of surgery for VSR and seek a comprehensive evaluation process for early mortality.

Methods: Patients undergoing surgical repair for postinfarction VSR in our institution retrospectively were evaluated from Jan. 2006 to Dec. 2019. The endpoint of the study was mortality within 30 days after VSR surgery, which was divided into survivors and nonsurvivors. The calibration and discrimination of two risk evaluation systems (European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) and the Society of Thoracic Surgeons (STS) risk score) in total were compared by Hosmer-Lemeshow, and the area under the receiver operating characteristic curve (AUC). Risk factors in subsets were assessed by logistic regression analysis.

Results: Twenty-three patients undergoing surgery for VSR repair were reviewed, and the early mortality after surgery was 34.8% (N = 8). The expected mortality predicted by EuroSCORE II was 24.3%, and that of the STS score was 12.2%. Both the EuroSCORE II and STS risk evaluation systems showed positive calibration in predicting mortality (H-L: P = 0.117 and P = 0.346, respectively) but poor discriminative power (AUC=0.633 and 0.575). Significant predictors determined by univariate analysis were concomitant coronary artery bypass grafting (CABG) (P = 0.035) and postoperative continuous renal replacement therapy (CRRT) (P = 0.008).

Conclusion: Early mortality of VSR after surgery remains high, and the evaluation process is complicated. The performances of the two risk evaluation systems were not optimal, but EuroSCORE II was more accurate than STS. Patients with lower preoperation EuroSCORE II, concomitant CABG during repair, and no need for CRRT after surgery may have a better early survival rate.

References

Ad N, Holmes SD, Patel J, Pritchard G, Shuman DJ, Halpin L. 2016. Comparison of EuroSCORE II, Original EuroSCORE, and The Society of Thoracic Surgeons Risk Score in Cardiac Surgery Patients. Ann Thorac Surg 102.

Anders J, Hans L, Per J, Marianne H, Kjell R. 2005. Surgical repair of post infarction ventricular septal defects: a national experience. Eur J Cardiothorac Surg. 27.

Arnaoutakis GJ, Zhao Y, George TJ, Sciortino CM, McCarthy PM, Conte JV. 2012. Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg. 94:436-43; discussion 443-4.

Assenza GE, McElhinney DB, Valente AM, et al. 2013. Transcatheter closure of post-myocardial infarction ventricular septal rupture. Circ Cardiovasc Interv. 6:59-67.

Barker TA, Ramnarine IR, Woo EB, et al. 2003. Repair of post-infarct ventricular septal defect with or without coronary artery bypass grafting in the northwest of England: a 5-year multi-institutional experience. Eur J Cardiothorac Surg. 24.

Birnbaum Y, Fishbein MC, Blanche C, Siegel RJ. 2002. Ventricular septal rupture after acute myocardial infarction. N Engl J Med. 347:1426-32.

Blanche C, Khan SS, Matloff JM, et al. 1992. Results of early repair of ventricular septal defect after an acute myocardial infarction. J Thorac Cardiovasc Surg. 104.

Carla P, de Villiers Jonker I, Lezelle B, Smit Francis E. 2012. Cardiac surgery risk-stratification models. Cardiovasc J Afr. 23.

Chew STH, Hwang NC. 2019. Acute Kidney Injury After Cardiac Surgery: A Narrative Review of the Literature. J Cardiothorac Vasc Anesth. 33.

Crenshaw BS, Granger CB, Birnbaum Y, et al. 2000. Risk factors, angiographic

patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation. 101:27-32.

French John K, Hellkamp Anne S, Armstrong Paul W, et al. 2010. Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI). Am J Cardiol. 105.

Gul KA, Murat K, Mete H, et al. 2013. Comparison of original EuroSCORE, EuroSCORE II and STS risk models in a Turkish cardiac surgical cohort. Interact Cardiovasc Thorac Surg. 16.

Jones BM, Kapadia SR, Smedira NG, et al. 2014. Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. Eur Heart J. 35:2060-8.

Labrousse L, Choukroun E, Chevalier JM, et al. 2002. Surgery for post infarction ventricular septal defect (VSD): risk factors for hospital death and long-term results. Eur J Cardiothorac Surg. 21.

Lingtong S, Wen G, Yiwei P, et al. 2018. Assessment of three risk evaluation systems for patients aged ≥70 in East China: performance of SinoSCORE, EuroSCORE II and the STS risk evaluation system. PeerJ. 6.

Loisance DY, Lordez JM, Deleuze PH, Dubois-Rande JL, Lellouche D, Cachera JP. 1991. Acute postinfarction septal rupture: long-term results. Ann Thorac Surg. 52.

Marek P, Jan H, Nedal O, Zdenek T, Jana S, Jan V. 2018. Surgical treatment of postinfarction ventricular septal defect: risk factors and outcome analysis. Interact Cardiovasc Thorac Surg. 26.

Matos D, Madeira M, Nolasco T, Neves JP. 2020. The role of extracorporeal membrane oxygenation in an acute basal ventricular septal rupture. Eur J Cardiothorac Surg. 57:799-800.

Moreyra AE, Huang MS, Wilson AC, Deng Y, Cosgrove NM, Kostis JB. 2010. Trends in incidence and mortality rates of ventricular septal rupture during acute myocardial infarction. Am J Cardiol. 106:1095-100.

Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. 1999. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 16.

O'Brien SM, Shahian DM, Filardo G, et al. 2009. The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Part 2—Isolated Valve Surgery. Ann Thorac Surg. 88.

Pang PY, Sin YK, Lim CH, et al. 2013. Outcome and survival analysis of surgical repair of post-infarction ventricular septal rupture. J Cardiothorac Surg. 8:44.

Ryoji I, Keizo K, Shigeru S, Setsuro O. 2007. Anesthesia for repair of ventricular septal rupture after acute myocardial infarction. J Clin Anesth. 19.

Shahian DM, O'Brien SM, Filardo G, et al. 2009. The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Part 1—Coronary Artery Bypass Grafting Surgery. Ann Thorac Surg. 88.

Shahian DM, O'Brien SM, Filardo G, et al. 2009. The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Part 3—Valve Plus Coronary Artery Bypass Grafting Surgery. Ann Thorac Surg. 88.

Shih T, Paone G, Theurer PF, McDonald D, Shahian DM, Prager RL. 2015. The Society of Thoracic Surgeons Adult Cardiac Surgery Database Version 2.73: More Is Better. Ann Thorac Surg. 100.

Simon M, Reda I, Arsène-Joseph B, et al. 2009. Postinfarction ventricular septal defects: towards a new treatment algorithm. Ann Thorac Surg. 87.

Singh V, Rodriguez AP, Bhatt P, et al. 2017. Ventricular Septal Defect Complicating ST-Elevation Myocardial Infarctions: A Call for Action. Am J Med. 130: 863.e1-863.e12.

Takahashi H, Arif R, Almashhoor A, Ruhparwar A, Karck M, Kallenbach K. 2015. Long-term results after surgical treatment of postinfarction ventricular septal rupture. Eur J Cardiothorac Surg. 47:720-4.

Wernovsky G, Wypij D, Jonas RA, et al. 1995. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 92:2226-35.

Published

2021-05-24

How to Cite

Wang, L., Hai, T., Feng, Y., Han, Q. ., Li, Y. ., Chen, Y. ., Yang, W. ., Zhao, Z., & Jiang, L. (2021). Perioperative Risk Assessment for Surgery of Consecutive Cases with Ventricular Septal Rupture: Seeking A Novel and Comprehensive Method. The Heart Surgery Forum, 24(3), E461-E466. https://doi.org/10.1532/hsf.3753

Issue

Vol. 24 No. 3 (2021)

Section

Articles

Author Disclosure & Copyright Transfer Agreement

In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.

A current form follows:

The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.

However, Publisher grants back to the author(s) the following:

  1. The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
  2. The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
  3. The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
  4. The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
  5. The right to make oral presentations of material from this work.

Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.

I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.

I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).

I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.

Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).